[ Price : $8.95]
FDA approves a Watson Laboratories ANDA for a generic version of UCB's Keppra XR.[ Price : $8.95]
Merck says that a planned late 2011 interim analysis of efficacy data from its Vytorin IMPROVE-IT study will be delayed until the ...[ Price : $8.95]
Elan adds former FDA commissioner Andrew von Eschenbach to its board of directors.[ Price : $8.95]
Federal Register Notice: FDA releases an ICH guidance on studies to evaluate the metabolism and residue kinetics of veterinary dru...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance on criteria found to be suitable for validating analytical methods used in veteri...[ Price : $8.95]
FDA lifts a partial clinical hold against an RXi Pharmaceuticals Phase 3 clinical trial involving breast cancer vacccine NeuVax (...[ Price : $8.95]
FDA approves an IND for AB Sciences Phase 3 study of masitinib to treat severe persistent asthma.[ Price : $8.95]
Federal Register Advance notice of proposed rulemaking: FDA extends the comment period on certain dosage forms of OTC sunscreen dr...